Norbrock Betamox LA 150 mg/ml INJ (100 ml)

Each ml contains: 150 mg (15% w/v) Amoxicillin (as Amoxicillin Trihydrate 17.21 %w/v)

Pharmaceutical Form

Suspension for injection. An off-white oily non-aqueous suspension.

Indications

In vitro Amoxicillin is effective against a wide range of Gram-positive and Gram-negative bacteria which include: Escherichia coli, Klebsiella pneumonia, Proteus species, Salmonella species, Staphylococci and Streptococci. Not effective against beta-lactamase producing organisms. Suitable for the control of infections due to susceptible microorganisms in cattle, sheep, pigs, dogs and cats where a single injection giving prolonged activity is required. It may also protect from secondary bacterial invasion due to sensitive organisms in cases where bacteria are not the initial cause of the disease. Indications include infections of: (a) Alimentary tract (b) Respiratory tract (c) Skin and soft tissue (d) Urogenital tract and, (e) In prevention of post-operative infection (treat before surgery).

Indications

In vitro Amoxicillin is effective against a wide range of Gram-positive and Gram-negative bacteria which include: Escherichia coli, Klebsiella pneumonia, Proteus species, Salmonella species, Staphylococci and Streptococci. Not effective against beta-lactamase producing organisms. Suitable for the control of infections due to susceptible microorganisms in cattle, sheep, pigs, dogs and cats where a single injection giving prolonged activity is required. It may also protect from secondary bacterial invasion due to sensitive organisms in cases where bacteria are not the initial cause of the disease. Indications include infections of: (a) Alimentary tract (b) Respiratory tract (c) Skin and soft tissue (d) Urogenital tract and, (e) In prevention of post-operative infection (treat before surgery).

To ensure the correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing. Cattle, sheep and pigs- By intramuscular injection only. Dogs and cats- By subcutaneous or intramuscular injection. The recommended dosage rate is 15 mg per kg bodyweight, repeatable if necessary after 48 hours. Massage the injection site. Shake the vial before use. Swab the septum before removing each dose. Use a dry sterile needle and syringe. A separate injection site should be used for each administration. Dose volume is equivalent to 1 ml per 10 kg bodyweight. If dose volume exceeds 20 ml, it should be divided and injected into two sites. As with other injectable preparations normal aseptic precautions should be observed. An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.